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ABSTRACT: Bidirectional cell-cell communication involving exosome-borne cargo such as 
miRNA, has emerged as a critical mechanism for wound healing. Unlike other shedding vesicles, 
exosomes selectively package miRNA by SUMOylation of heterogeneous nuclear 
ribonucleoproteinA2B1 (hnRNPA2B1). In this work, we elucidate the significance of exosome in 
keratinocyte-macrophage crosstalk following injury. Keratinocyte-derived exosomes were 
genetically labeled with GFP reporter (Exoκ-GFP) using tissue nanotransfection and were isolated 
from dorsal murine skin and wound-edge tissue by affinity selection using magnetic beads. Surface 
N-glycans of Exoκ-GFP were also characterized. Unlike skin exosome, wound-edge Exoκ-GFP
demonstrated characteristic N-glycan ions with abundance of low base pair RNA and were 
selectively engulfed by wound-macrophages (ωmϕ) in granulation tissue. In vitro addition of 
wound-edge Exoκ-GFP to proinflammatory ωmϕ resulted in conversion to a proresolution 
phenotype. To selectively inhibit miRNA packaging within Exoκ-GFP in vivo, pH-responsive 
keratinocyte-targeted siRNA-hnRNPA2B1 functionalized lipid nanoparticles (TLNPκ) were 
designed with 94.3% encapsulation efficiency. Application of TLNPκ/si-hnRNPA2B1 to murine dorsal 
wound-edge significantly inhibited expression of hnRNPA2B1 by 80% in epidermis compared to 
TLNPκ/si-control group. Although no significant difference in wound closure or re-epithelialization 
was observed, TLNPκ/si-hnRNPA2B1 treated group showed significant increase in ωmϕ displaying 
proinflammatory markers in the granulation tissue at day 10 post-wounding compared to TLNPκ/si-
control group. Furthermore, TLNPκ/si-hnRNPA2B1 treated mice showed impaired barrier function with 
diminished expression of epithelial junctional proteins, lending credence to the notion that 
unresolved inflammation results in leaky skin. This work provides insight wherein Exoκ-GFP are 
recognized as a major contributor that regulates macrophage trafficking and epithelial barrier 
properties post-injury. 
KEY WORDS: exosome, tissue nanotransfection, keratinocyte-targeted lipid nanoparticles, 
macrophage, wound healing.
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The dynamic cellular events following cutaneous injury rely on bidirectional cell-cell 
communication for efficient wound healing. Such crosstalk is traditionally known to occur via 
paracrine effects.1, 2 A recent paradigm has emerged wherein the predominant mechanism of 
cellular communication is attributable to extracellular vesicles (EV).3-7 These EV have distinct 
structural and biochemical properties depending on their intracellular site of origin that affects 
their biological function.8 A majority of these vesicles having diameters ranging from 50-1000 nm 
originate from the plasma membrane and are often referred to as microvesicles, ectosomes, 
microparticles, and exovesicles.8 Exosomes are a major class of EV (typically 30–150 nm in 
diameter) of endocytic origin released by all cell types following fusion of multi-vesicular bodies 
(MVB) with the plasma membrane.9, 10 Exosomes carry a distinctive repertoire of cargo such as 
miRNAs.11 RNA profiling of exosomes showed differences in miRNA abundance compared to the 
parent cells, suggesting that parent cells possess a sorting mechanism that guides specific 
intracellular miRNAs to enter into the exosomes.12-14 SUMOylation of heterogeneous nuclear 
ribonucleoprotein A2B1 (hnRNPA2B1) has been implicated as a predominant mechanism of 
miRNA packaging within exosomes.15 Within the cell, miRNAs have specific sequence motifs 
that control their localization into exosomes. Binding of hnRNPA2B1 to the miRNA by 
recognition of these motifs controls their loading into exosomes. Moreover, SUMOylation of 
hnRNPA2B1 regulates the binding of hnRNPA2B1 to miRNAs. Given the presence of such a well-
coordinated sorting mechanism, it is apparent that cell-cell crosstalk via exosomes is an active 
process. Such process is distinct from cellular communication mediated via shedding of other 
membrane vesicles that also carry biomolecules such as miRNA as cargo that is not selectively 
packaged in these vesicles. Lack of efficient isolation techniques of exosomes from other 
membrane vesicles of similar size have led to conclusions that are primarily derived from a 
heterogenous EV pool. This lack of discrimination among various membrane vesicles dampens 
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the potential significance of exosomes in cellular communication and has impaired discovery of 
the role of exosome of specific cellular origins in communication. 
The putative role of keratinocytes in wound healing and inflammation is well documented.16-19 At 
the wound site, cells of myeloid origin such as monocytes and macrophages are primarily 
responsible for mounting an early inflammatory response to injury.20-23 Both robust mounting of 
inflammation as well as timely resolution are key to successful tissue repair. The role of 
keratinocytes for the resolution of inflammation remains unclear and debated. This study rests on 
our observation that at the site of injury, EV of keratinocyte origin are critical for conversion of 
the myeloid cells into fibroblast-like cells in the granulation tissue.19 The objectives of this work 
were to isolate exosomes of keratinocyte origin at the wound-edge and to delineate their 
significance in the resolution of inflammation at the wound site. This work shows that keratinocyte 
derived exosomes carry miRNAs that direct resolution of macrophage numbers and function 
within the granulation tissue and are critical for functional wound closure.
RESULTS AND DISCUSSION
Identification and isolation of keratinocyte-derived exosomes in murine skin. To circumvent 
the EV complexity found in vivo in complex tissues, we employed an in vitro system and isolated 
exosomes from the heterogenous pool of EV derived from cultured keratinocytes. According to 
EVPedia24 and Exocarta,25 the three tetraspanins CD9, CD63 and CD81 are reliable markers of 
exosomes.26  In the interest of rigor, we employed a two-step process to isolate pure exosome. 
First, EV were isolated from keratinocyte-conditioned media using differential ultracentrifugation 
(Figure S1A). Second, the heterogenous EV were incubated with superparamagnetic DynabeadsTM 
conjugated with antibodies for CD9, CD63 and CD81 (Figure S1A). From the heterogenous EV 
mixture, only the tetraspanins expressing exosomes were trapped leaving the membrane particles 
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and apoptotic bodies in the flow through.  We tested all the nine criteria set forward by EV-track 
for transparent reporting (Figure S1). The size and concentration of the exosomes were analyzed 
by nanoparticle tracking analysis (NanoSight™) and Scanning electron microscopy (SEM) (Figure 
S1B-C). The density of the isolated exosomes was found to be 1.16g/ml. The isolated exosomes 
showed abundance of other reported exosome markers such as Alix, TSG101, HSP90 and Flotilin 
1 (Figure S1D). The purity of the isolation was tested by immunoblotting of GM130 and Prohibitin 
that are reported as major contaminants of exosome preparation by EV-track.27 Additional 
quantitative analysis such as flow cytometry of these DynabeadsTM post-adsorption with exosomes 
following incubation with phycoerythrin (PE) conjugated TSG101 (TSG101-PE) antibody showed 
an increased shift in fluorescence intensity (Figure S1E). Furthermore, binding of PE tagged 
TSG101 antibody was tested by fluorescence anisotropy (Figure S1F) and fluorescence correlation 
spectroscopy (Figure S1G). Binding of TSG101-PE by the resuspended isolated exosomes 
hindered their free rotation as shown by a marked increase in fluorescence anisotropy (Figure S1F). 
TSG101-PE had fast and unhindered diffusion when resuspended in PBS or in the presence of EV 
flow through. However, in the presence of exosomes, diffusion of TSG101-PE slowed down as 
shown by shifted autocorrelation curve (Figure S1G). These data validated that the two-step 
isolation process was successful in separating exosomes from the heterogenous EV pool. This 
method of exosome isolation was reported in EV-track (EV190103) with a preliminary EV-
METRIC of 100%.28
The approach described above was applied for isolation of exosomes in vivo. Recent reports have 
highlighted the role of exosome in cutaneous wound healing.29, 30 Analysis of EV concentration 
from murine skin and day 5 wound-edge tissue (< 2mm from wound-edge) showed significant 
increase in EV as well as exosomes in day 5 wound-edge tissue (Figure 1A). Quantitative analysis 
revealed that exosome represents only about 10% of the total EV pools. In addition to the resident 
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cells such as keratinocytes and fibroblasts, day 5 wound-edge tissue contains infiltrated blood-
borne cells including macrophages. Thus, to understand whether the increase abundance of 
exosome at the wound-edge is due to increased release of exosomes by additional biogenesis in 
resident cells or contributed by infiltrating cells, it becomes critical to segregate the exosomes 
based on their cellular origin. 
Our previous work has recognized the critical role of keratinocytes derived EV in the conversion 
of injury-site myeloid cells to fibroblast-like cells in granulation tissue.19  However the 
significance of exosomes in such keratinocyte-myeloid cell crosstalk remains unknown. Since one 
or more of the three tetraspanins CD9, CD63 and CD81 are expressed in all exosomes, we designed 
three murine keratin 14 (K14) promoter-driven plasmids that encode for CD9, CD63 and CD81 
with “in frame” GFP reporter (Figure 1B). Such promoter-driven plasmids allow expression of 
GFP tagged CD markers only in keratinocytes. The specificity of the plasmid cocktail was tested 
in murine keratinocytes, fibroblasts and m (Figure S2A-C). We tested the hypothesis that in 
vivo topical delivery of these three plasmids would result in the expression of GFP in all exosomes 
that are of keratinocyte origin. We have previously reported that cutaneous delivery of 
reprogramming molecules via tissue nanotransfection (TNT) was efficient and effective in directly 
reprogramming dermal fibroblast cells into a variety of functionally distinct lineages.31 We have 
now generated a modified TNT silicon chip (TNT2.0)  with longer needle height of 170m and 
pore diameter of 4m (Figure 1C). Modifying the electrical potential applied between the cargo 
within the chip and skin led to stepwise increases in the depth of transfection of fluorescein amidite 
(FAM)-labeled DNA (Figure 1D, Figure S2D) in wild type C57BL/6 mice. Delivery of these three 
K14 promoter-driven plasmids via TNT followed by super-resolution confocal microscopy 
demonstrated presence of exosome with GFP reporter expression in epidermis as well as in dermis 
Page 6 of 58






























































(Figure 1E, Figure S2E). Because the GFP reporter protein was cloned in frame with the CD9, 
CD63 and CD81, pull down of GFP using magnetic traps is expected to isolate the Exoκ-GFP. 
Keratinocyte-derived exosomes were isolated from the tissue homogenate using GFP-magnetic 
traps followed by separating the exosomes from the beads using elution buffer (Figure 1F). The 
resultant flow through was further ultracentrifuged and the non-keratinocyte derived exosome 
(Exonon-GFP) were isolated using pan-CD superparamagnetic beads (Figure 1F). The size and 
concentration of Exoκ-GFP, Exonon-GFP and flow through were further examined using nanoparticle 
tracking analysis (Nanosight™) (Figure 1G). Scanning electron microscopy of Exoκ-GFP revealed 
presence of exosomes of different size (Figure 1H). Adsorption of Exoκ-GFP on GFP-Trap was 
tested by fluorescence correlation spectroscopy (Figure 1I) and fluorescence anisotropy (Figure 
1J). Flow cytometric analysis of GFP-trap beads post-adsorption with Exoκ-GFP following 
incubation with fluorescently tagged antibodies of exosome marker such as TSG101-PE, Alix-
FITC, Flotilin1-PE and HSP90-FITC showed an increase in fluorescence intensity (Figure 1K). 
These findings demonstrate that the GFP-trap approach was successful in isolating Exoκ-GFP from 
murine tissue homogenate.
Ultracentrifugation is widely held as a gold standard for exosome isolation. In the interest of rigor, 
Exoκ-GFP was subjected to direct comparison with exosomes isolated using differential 
ultracentrifugation. Murine keratinocytes were transfected with the three K14 promoter-driven 
plasmids to label the exosomes with GFP-reporter. Exosomes were isolated from the cell culture 
supernatant using GFP-Trap and compared with exosomes isolated using ultracentrifugation 
(Figure 2A). No difference in size, shape and binding property were observed between the 
exosomes isolated using the two methodologies (Figure 2B-F).
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Characterization of keratinocyte-derived exosomes isolated from murine skin and wound-
edge tissue. Isolation of Exoκ-GFP from wild type mice showed a significant increase in day 5 
wound-edge Exoκ-GFP compared to skin (Figure 3A). High-resolution automated electrophoresis of 
RNA isolated from Exoκ-GFP showed abundance of small bp RNA (<100 bp) in day 5 wound-edge 
tissue (Figure 3B). These data suggest Exo-borne miRNA signals are dispatched from resident 
keratinocytes of the wound-edge tissue to enable crosstalk with visiting immune cells.
N-glycans molecule facilitate the uptake of keratinocyte-derived exosomes by macrophage at 
the wound-edge. Based on our previous work that demonstrated the critical role of EVs of 
keratinocyte origin in the conversion of injury-site myeloid cells to fibroblast-like cells of 
granulation tissue,19  it is plausible that the exosomes released from the keratinocytes are likely 
engulfed by the m. Immunohistochemistry followed by super-resolution confocal microscopic 
images revealed that unlike the skin adjacent to wound, the Exo-GFP at the wound-edge were 
selectively engulfed by the m (Figure S3A-C). Macrophage has abundant membrane-bound C-
type lectin receptors that share a common carbohydrate recognition domain.32  Such receptors are 
critical for binding to specific carbohydrate structures of endogenous self-molecules.33  The C-
type lectin receptors on  a macrophage membrane are able to bind branched sugars with terminal 
mannose, fucose, or N-acetyl-glucosamine, and mediate both endocytosis and phagocytosis.34 
Intrigued by the site specific selective uptake of Exo-GFP by the m, we tested the hypothesis 
that at the wound-edge, the Exo-GFP surface is selectively modified to facilitate uptake by the 
immune cells.  Exoκ-GFP N-glycans were analyzed by capillary electrophoresis-mass spectrometry 
(CE-MS) to identify N-glycan compositions.35, 36 Released, purified, and methylamidated N-
glycans were labeled with Girard’s reagent T (GT) to impart a single positive charge for 
electrophoretic separation and enhanced ionization efficiency during CE-MS analysis. The 
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compositions and tentative structures of the glycans were based on detected mass and ExPASy 
GlyConnect database.37 Through CE-MS, 51 N-glycan compositions were identified in total (Table 
S1), among which 19 and 7 glycans were exclusively present in skin and day 5 wound-edge tissue, 
respectively. Furthermore, N-glycans conserved in both skin and day 5 wound-edge differ in their 
relative intensities (Figure 4). Glycans with m/z 855.349 (corresponding to 
Hex4HexNAc3Neu5Gc1) existed in both Exo-GFP samples with similar relative intensities. 
However, glycan ions at m/z 877.8542 (Hex5HexNAc4) were more abundant in skin Exo-GFP, 
whereas glycan ions at m/z 707.281 (Hex6HexNAc5) were found exclusively in skin Exo-GFP. 
Similarly, glycan ions at m/z 720.232 (Hex10HexNAc2) were only detected in wound edge Exo-
GFP. The difference in abundance of glycan molecules on Exo-GFP surface lends credence to the 
notion that they play a role in uptake by m during wound healing. In vitro inhibition of the C-
type lectin receptors in day 3 m  resulted in decreased uptake of EXO-GFP (Figure S3C-D and 
Supp. Movie S3-4). It was thus of interest to test whether Exo-GFP determines the fate of myeloid 
cells at the wound site. The conventional M1/M2 nomenclature is not appropriate for m  
 Recognizing the ambiguity in macrophage nomenclature specifically for tissue macrophages,40-
42 we classify in vivo m on the basis of the proinflammatory or proresolution/healing phenotype. 
Incubation of day 3 m (proinflammatory phenotype) with Exo-GFP and Exonon-GFP isolated from 
day 3 wound-edge tissue (Figure S3E) caused overt phenotypic changes. On day 7, down-
regulation of proinflammatory genes such as Tnf, Nos2, Cd74 was associated with upregulation 
of the proresolution gene Cl3 (Figure S3F).
Design and synthesis of keratinocyte specific lipid nanoparticles to inhibit miRNA packaging 
within exosome. Exosomes carry a distinctive repertoire of cargo such as miRNAs.11 Previous 
studies on RNA profiling of exosomes showed difference in miRNA abundance compared to the 
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parent cells, suggesting that parent cells possess a sorting mechanism that guides specific 
intracellular miRNAs to enter into the exosomes.12-14 Should the cues for conversion of wound 
macrophage from a proinflammatory to a proresolution state be driven by keratinocytes via 
miRNA packaged in exosome, then inhibition of such packaging machinery would result in 
accumulation of proinflammatory macrophage in vivo. SUMOylation of heterogeneous nuclear 
ribonucleoprotein (hnRNPA2B1) has been implicated in miRNA packaging within exosomes.15 
ExomiRs contain a distinct signature motif known as exomotif.  Exomotifs are recognized by 
heterogeneous nuclear ribonucleoprotein (hnRNPA2B1). Exosomal loading of exomiRs is thus 
controlled by hnRNPA2B1.15 SUMOylation of hnRNPA2B1 causes gain in function, thus 
improving exosomal loading of miRNA. Thus, it is plausible that inhibition of hnRNPA2B1 in the 
keratinocytes would impair the microRNA packaging in Exo-GFP. We have previously reported 
keratinocytes targeted delivery of oligonucleotide using functionalized lipid nanoparticles.43 Using 
a similar approach, we designed keratinocyte-targeted siRNA functionalized lipid nanoparticles 
(TLNP) to inhibit the expression of hnRNPA2B1 in keratinocytes (Figure 5A). Unlike our 
previous report, the DODAP was replaced by DODMA containing pH-sensitive tertiary amine 
(Figure 5A). Additionally, the keratinocyte-targeting peptide ASKAIQVFLLAG (A5G33) peptide 
was conjugated with NHS-PEG2000-DSPE in one-step process for better purification (Figure 5B). 
A high concentration of Tween 80 (20 mol%) used in nanoparticle formulation for a reduction in 
the particle size, stabilization of the nanoparticle and increased the skin permeability for local 
delivery. The Zeta potentials (ζ) of TLNP changed from +20 mV to –20 mV in the pH range of 3 
to10 demonstrating the pH-sensitive activity of TLNP (Figure 5C). Within physiological limit, 
the neutral or mild positive charge of the lipid nanoparticles evades uptake by the 
reticuloendothelial system (RES), prolong circulation time and reduce the toxicity.44-46 The siRNA 
encapsulation efficiency was found to be more than 90% when  measured by Quant-iT RiboGreen 
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RNA Kit . Gel retardation assay further demonstrated that the siRNA formed complexes with lipid 
nanoparticles (Figure 5D). The average size of the lipid nanoparticles was found to be 108.9 nm 
(Figure 5E-F).  In a mixed culture comprising of keratinocytes, endothelial cells, and fibroblasts, 
TLNP was specifically taken up by the keratinocytes within 4 hours demonstrating targeting 
specificity and efficiency (Figure 6A-B, Figure S4A-B). This TLNP was not cytotoxic in 
keratinocytes as determined by LDH release (Figure 6C), metabolic viability (Figure S4C), and 
propidium iodide exclusion (Figure S4D). The uptake of TLNP by murine keratinocytes was more 
rapid compared to non-TLNP (Figure 6C, Figure S4E).  All materials used for its formulation 
have prior history of FDA approval for human use and thus offer a clear translational advantage.
Functional characterization of keratinocyte-specific lipid nanoparticles to inhibit miRNA 
packaging within exosome. To test whether our siRNA functionalized keratinocyte-targeted lipid 
nanoparticles are effective in inhibiting the packaging of the miRNA within Exo-GFP, we utilized 
commercially available XMIR technology from SBI System Biosciences. XMIR technology takes 
advantage of normal cellular processes to package a specific miRNA into exosomes using the 
XMotif RNA sequence tag. Transfection of XmiR-21-5p to human keratinocytes increased the 
abundance of miR-21-5p in cells as well as in the exosome isolated from keratinocytes cultured 
conditioned media (Figure S5A-B). Delivery of TLNP/si-hnRNPA2B1 to human keratinocyte 
significantly suppressed hnRNPA2B1 expression (Figure 7A-B). Transfection of XmiR-21-5p to 
cells treated with either TLNP/si-control or TLNP/si-hnRNPA2B1 showed no significant difference in 
the number of exosomes released by keratinocytes (Figure 7C). However, quantification of 
exosomal RNA content and miR-21-5p abundance within the exosome from TLNP/si-hnRNPA2B1 
and XmiR-21-5p treated keratinocytes showed significant reduction suggesting that TLNP/si-
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hnRNPA2B1 was successful in inhibiting the miRNA packaging within the exosome in keratinocytes 
(Figure 7D-F).
Delivery of keratinocyte-specific lipid nanoparticles encapsulating si-hnRNPA2B1 
compromised quality of wound closure. Based on observations from in vitro studies on the role 
of ExoGFP in the conversion of macrophage phenotype (Figure S3E), we postulated that in vivo 
delivery of TLNP/si-hnRNPA2B1 to inhibit miRNA packaging in keratinocytes will compromise the 
quality of wound healing in mice. Comparable to findings of in vitro studies, delivery of TLNP/si-
hnRNPA2B1 to murine keratinocyte significantly suppressed hnRNPA2B1 expression (Figure 8A-D, 
Figure S6A). Interestingly, no significant difference in the number of exosomes released at the 
wound-edge was observed (Figure S6B). Furthermore, wound closure in both TLNP/si-control and 
TLNP/si-hnRNPA2B1 groups were comparable (Figure 8E, Figure S6C-D). However, at day 10 in 
mice treated with TLNP/si-hnRNPA2B1, persistent accumulation of inflammatory cells was noted in 
the granulation tissue (Figure 8F). These inflammatory cells were identified to be as m (Figure 
8G, Figure S6E). Unlike the scanty m that exhibit proresolution marker arginase in TLNP/si-
control group, these m abundant in TLNP/si-hnRNPA2B1 treated group expressed proinflammatory 
marker iNOS even at day 10 post-wounding (Figure 8H-I, Figure S6F-G). Such increased 
abundance of m in the granulation tissue of TLNP/si-hnRNPA2B1 treated group may not be 
attributed to increased recruitment on the basis of comparable neutrophil or macrophage counts on 
day 3 post-wounding (Figure S7). These m exhibiting proinflammatory phenotype, persisted 
in the repaired skin even after the wound was closed following TLNP/si-hnRNPA2B1 treatment 
(Figure S8). Such presence of proinflammatory m at the granulation tissue in mice treated with 
TLNP/si-hnRNPA2B1 lend credence to the notion that the cues for conversion of m from 
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proinflammatory to proresolution state comes as miRNA packaged in keratinocyte-derived 
exosomes. 
To investigate the significance of abundant proinflammatory m in the day 10 granulation tissue 
of TLNP/si-hnRNPA2B1 treated mice, we tested the functional property of the re-epithelialized skin 
by measuring the barrier function post-closure. The barrier function of the TLNP/si-hnRNPA2B1 group 
was significantly compromised demonstrating that indeed wound closure was impaired (Figure 
9A). Restoration of barrier function of the repaired skin is a necessary component of functional 
wound healing.44, 47-49 The terminally differentiating structural protein loricrin forms 70-80% of 
the cornified envelope contributes to the protective barrier function of skin.49-51 The abundance of 
loricrin in the re-epithelialized skin was significantly compromised following TLNP/si-hnRNPA2B1 
treatment (Figure 9B). Furthermore, lower expression of other junctional proteins such as ZO-1, 
ZO-2, filaggrin and occludins was also observed at day 10 post-wounding in TLNP/si-hnRNPA2B1 
treated group compared to TLNP/si-control group (Figure 9C). Taken together, these observations 
explain how functional wound closure is impaired in mice treated with TLNP/si-hnRNPA2B1. Thus, 
impairment in miRNA packaging in keratinocyte exosomes of the skin impaired resolution of 
inflammation and compromised functional wound closure. 
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In summary, we developed a method of isolating ExoGFP  in tissue for studying keratinocyte-
exosome crosstalk during wound healing. This work provides critical insight into the significance 
of ExoGFP in the resolution of wound inflammation and determination of functional wound 
closure. ExoGFP showed abundance of small bp RNA (<100 bp) in day 5 wound-edge tissue.  
Exo-borne miRNA signals enable crosstalk between resident keratinocytes of the skin with 
visiting m.  Glycan ions with high mannose was only detected in wound-edge Exo.  Wound 
macrophages are known to possess mannose receptors. Mannose-functionalization is commonly 
used to target nanoparticles for m uptake. In this work, Exo were  taken up by  in the wound-
edge tissue. Such uptake caused phenotypic changes in m consistent with the resolution of 
inflammation. Blockade of miRNA transfer via ExoGFP to m by knocking down hnRNPA2B1 
caused persistence of proinflammatory m Thus, exosomal miRNA packaging in skin 
keratinocytes modify wound inflammation response. Impaired resolution of wound inflammation, 
caused as above, hindered functional wound healing by compromising restoration of skin barrier 
function at the site of repair.  Findings of this work lay the framework of an emerging paradigm 
wherein exosome-borne molecular signals drive crosstalk between different cellular compartments 
in a way that directly determines the fate of wound healing outcomes. Such advancement in our 
understanding of wound healing unveils heretofore unknown therapeutic targets that may be 
exploited to design productive wound-care strategies.  
Page 14 of 58































































Cells and cell culture. Immortalized human keratinocytes (HaCaT) were grown in Dulbecco’s 
low-glucose (1g/L) modified Eagle’s medium (Life Technologies, Gaithersburg, MD) as described 
previously.52 Human dermal microvascular endothelial cells (HMECs) were cultured in MCDB-
131 medium supplemented 10 mm l-glutamine, and 100 IU/ml of penicillin, 0.1 mg/ml of 
streptomycin (Invitrogen), as described previously.53 Human skin fibroblast BJ cells (ATCC® 
CRL-2522™) were obtained from ATCC and were cultured in Eagle's Minimum Essential 
Medium, (Catalog No. 30-2003) as per the instruction provided. Mouse keratinocytes (KERA-
308) were purchased from Cell line Services (CLS Germany) and were cultured in Dulbecco’s 
high-glucose (4.5g/L) modified Eagle’s medium (Life Technologies, Gaithersburg, MD).  Primary 
mouse embryonic fibroblasts were purchased from Millipore Sigma (PMEF-HL) and were 
cultured as per manufacturer’s instruction. For isolation of wound macrophages (ωmϕ), circular 
(8 mm) sterile Polyvinyl alcohol (PVA) sponges were implanted subcutaneously on the backs of 
8 to 12 week-old mice.54 Sponge-infiltrated wound mϕ (CD11b+) were obtained from day 3 wound 
cell infiltrate by magnetic bead-based sorting as previously described.55, 56 The isolated cells were 
cultured in RPMI-1640 media. The cells were maintained in a standard culture incubator with 
humidified air containing 5% CO2 supplemented with 10% FBS and 1% antibiotic-antimycotic 
(AA) (Life Technologies) unless stated otherwise. All experiments involving isolation or uptake 
of exosomes were performed with exosome depleted FBS. 
Isolation of exosome from cell culture media (EV-TRACK ID: EV190103). Cell culture 
supernatant (using cells cultured with media described above and 10% Gibco Exosome-Depleted 
FBS (ThermoFisher Scientific)) was centrifuged at 3400g for 15 min and the supernatant was 
collected. Extracellular vesicles were isolated from the supernatant using differential 
ultracentrifugation (Beckman Coulter Optima Max-XP Ultracentrifuge, rotor TLA120.2) as 
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described in figure S1.  Pellets were washed by resuspending in PBS and re-pelleting via a second 
round of ultracentrifugation. These pellets were then resuspended in PBS and incubated overnight 
at 4°C with magnetic CD9, CD63 and CD81 Dynabeads (Invitrogen). The exosomes-attached to 
the beads were magnetically separated from flow through using a magnetic microcolumns (µ 
columns from Miltenyi Biotec MACS). The flow through eluent (membrane particles and 
apoptotic bodies) was kept and re-pelleted for further analysis (2h at 245,000g). For Western blot 
and flow cytometry, the exosomes were not removed from the magnetic beads. For Nanoparticle 
Tracking Analysis or SEM imaging, exosomes were eluted from the beads using elution buffer 
(ExoFlow Exosome Elution Buffer, System Biosciences) as per manufacture’s protocol. This 
method was submitted to EV track.27  
Isolation of keratinocyte-derived exosome from murine tissue.  EVs and keratinocyte-derived 
exosomes were isolated from mouse tissue following transfection with Keratin 14 promoter driven 
plasmids encoding murine CD63, CD9 and CD 81 with GFP reporter “in frame”. The murine skin 
and wound-edge tissue were collected and homogenized, suspended in PBS and vortexed to release 
exosomes from tissue. The solution was briefly centrifuged and the supernate collected and 
centrifuged at 5000g for 15 min followed by 20,000 g for 45 min. The supernatant was incubated 
overnight at 4°C with GFP-Trap magnetic agarose beads (Chromotek Catalog # gtma-100) (12 µL 
GPF-Trap beads per 0.15 g tissue). Exosome isolation from GFP-Trap beads utilized magnets to 
isolate the beads, enabling the eluent to be removed. The GFP-Trap beads were washed thrice in 
PBS. Finally, elution of intact beads was accomplished by mixing with glycine (0.2M, pH 3) for 
30 seconds, a process that was repeated 5 times. The pH was adjusted to 7.4 using 1.0 M Tris, and 
EXO-GFP pellets were collected by ultracentrifugation (2 h at 245,000g). The flow through was 
next incubated with magnetic pan-CD beads (Miltenyi Biotec Catalog # 130-117-039) for 2 h at 
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room temperature that were isolated from flow through to recover the non-keratinocytes derived 
exosome as described above for Invitrogen Dynabeads.   
Fluorescence correlation spectroscopy (FCS). Exosome-protein binding was also measured by 
the change in diffusion and anisotropy of a fluorescently labeled antibody (TSG101-PE) incubated 
in the presence of exosomes or other extracellular vesicles using a two-channel fluorescence 
correlation spectroscopy system (Confocor 2, Zeiss) attached to an Axiovert200 M inverted 
microscope (Zeiss).57 The system measures a characteristic diffusion time (τD) of a fluorophore as 
determined by fitting fluorescent decay within a confocal volume to an autocorrelation curve using 
the Eq. (1), where N is particle concentration and Q is a factor relating to the ellipticity of the 
confocal volume:

























Autocorrelation best fit curves identify change in particle diffusion with curves shifted to the left 
demonstrating faster diffusion (smaller τD); exemplary best fit curves are shown, where the curves 
are fitted using a one-component fit identifying an average characteristic diffusion time for the 
fluorophores. For fluorophores bound to exosomes, this will provide qualitative evidence of 
exosomal binding.  
Fluorescence anisotropy. Fluorescence anisotropy experiments were conducted using a two-
channel fluorescence correlation system where both channels are equipped with crossed analyzers, 
one perpendicular and one parallel to the emitted laser light. The emitted light divides into two 
separate beams of equal intensity, which are guided into each of the two APD channels. The 
anisotropy can be calculated using Eq. (2). 
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r = (I1  - I2 )/ (I1  + 2I2) (2)
where I1 and I2  are the intensities of the parallel and perpendicular channels, respectively.57, 59 A 
correction factor for difference in analyzer sensitivity was not utilized as this factor does not alter 
significance of change in anisotropy between different conditions. Anisotropy experiments are 
complementary to autocorrelation analysis because they provide information about the short-range 
mobility of the tracer molecules, namely the change in rotational diffusion. Autocorrelation curves 
shown are examples of curves collected with concentration normalized; anisotropy data were 
collected using 10s runs for each data point.
N-Glycan analysis. Denaturation solution, consisting of 0.1% SDS (Bio-Rad Laboratories, Inc.,
Hercules, CA) and 0.2% β-mercaptoethanol (Sigma-Aldrich, St. Louis, MO) in 50 mM sodium 
phosphate buffer (pH 7.5), was added to the exosome sample and incubated at 60 °C for 1 h. After 
that, nonidet P40 substitute (NP-40, Roche Diagnostics Corp, Indianapolis, IN) was added to 
encapsulate SDS. The sample was then incubated with Peptide N-Glycosidase F (PNGase F, New 
England BioLabs, Inc., Ipswich, MA) at 37 °C for 18 h. Cleaved N-glycans were purified through 
solid-phase extraction on an active charcoal phase (Micro SpinColumns, Harvard Apparatus, 
Holliston, MA). For methylamidation,60, 61 purified and dried glycans were dissolved in 5 µL of 
DMSO (Fisher Chemical, Fair Lawn, NJ), containing 2 M methylamine hydrochloride (Sigma-
Aldrich, St. Louis, MO) and 1 M 4-methylmorpholine (Sigma-Aldrich, St. Louis, MO), and 5 µL 
of 100 mM (7-Azabenzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate 
(PyAOP, Sigma-Aldrich, St. Louis, MO). The reaction proceeded at room temperature in the dark 
for 4 h and was terminated with addition of 240 µL of 85% acetonitrile (OmniSolv, Billerica, MA). 
Methylamidated N-glycans were purified through solid-phase extraction on a hydrophilic 
interaction phase (Amino Micro SpinColumns, Harvard Apparatus, Holliston, MA). To impart a 
+1 charge for electrophoresis, glycans were labeled with Girard’s reagent T (GT; Sigma-Aldrich,
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St. Louis, MO). Briefly, 25 µL of 0.02 M GT in 10% (v/v) acetic acid was added to purified glycans 
and incubated at 55 °C for 4 h, and the reaction mixture was dried in a CentriVap concentrator to 
remove excess acetic acid and water.
CE-MS analysis35 of the N-glycans was conducted on a CESI 8000 instrument (SCIEX 
Separations, Framingham, MA) with a neutral capillary cartridge (30 μm i.d. x 90 cm length; Opti-
MS, B07368, SCIEX Separations) and an Orbitrap Fusion Lumos mass spectrometer (Thermo 
Fisher, Waltham, MA). GT-labeled N-glycans were dissolved in 10 μL of 0.5% acetic acid (v/v). 
Sample was injected into the capillary hydrostatically at 3 psi for 25 s and electrophoretically 
separated with an applied potential of 25 kV and pressure of 3 psi. The capillary was connected to 
the mass spectrometer through an electrospray interface with an applied potential of 1090 V. MS 
data from positive ions ranging from 200 to 2000 m/z were collected. The detected masses were 
searched on Expasy GlycoMod, and tentative structures were assigned based on previously 
reported structures on Expasy GlyConnect. Relative intensities of the N-glycans were calculated 
with the Thermo Xcalibur Qual Browser algorithm Genesis where the signal was boxcar averaged 
(7 points) with mass tolerance 30 ppm. 
Flow cytometry. Exosome markers were assessed using PE anti-TSG101 (1:100, NB200-112PE, 
Novus Biologicals), PE anti -flotillin-1 (1:200, ab225165, Abcam) by incubating the antibodies at 
the noted concentrations with the beads for 90 minutes at room temperature. Additional exosome 
markers, anti-Alix (1:100, 92880 Cell Signaling Technology), and anti-HSP90 (1:100, ab59459, 
Abcam) were first incubated with beads for 90 minutes at room temperature followed by magnetic 
separation using PBS to remove excess antibodies and incubation of beads next with the secondary 
antibody. Goat Anti-Rabbit IgG Alexa Fluor 488 (1:200, ab150077). PE fluorescence was 
determined using PE channel.  Alexa Fluor 488 fluorescence was determined using FITC channel. 
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For the membrane integrity assay, human keratinocytes were incubated with Propidium iodide 
(1mg/ml) and the percentage of viable cells was measured in FL2 channel.62 Heat killed human 
keratinocytes were used as positive control. Samples were run on an Accuri C6 flow cytometer 
(Accuri Cytometers, MI, USA) or LSRFortessa X‐20 flow cytometers (BD Biosciences, CA, 
USA). Data were collected from 5000 – 10,000 events at a flow rate of 250-300 events/s and 
analyzed using FlowJo software (Tree Star, OR, USA).
Synthesis of DSPE-PEG2000-A5G33. DSPE-PEG2000-A5G33 was synthesized through the 
conjugation of A5G3344 (sequence: ASKAIQVFLLAG, Genscript, NJ, USA) and DSPE-PEG2000-
NHS (Nanocs, Boston, MA, USA).  Lipid peptide conjugation was done by dissolving 20 mg 
DSPE-PEG2000-NHS in dimethyl sulfoxide (DMSO) with a solution of A5G33 in DMSO and 
10 µL trimethylamine (TEA). The reaction was performed in an oxygen-free environment 
(nitrogen purge) at room temperature for 24 hours. The resulting mixture was dialyzed against 
deionized water using a slide-a-lyzer dialysis cassette (Molecular weight cut-off, MWCO 3500) 
for 48 h to remove impurities. The final solution was lyophilized and the powder was stored at 
−20 °C for further use. DSPE-PEG2000-A5G33 was characterized using MALDI-TOF mass 
spectrometry (15 T FT-ICR Bruker Daltonics Inc.).
Preparation of keratinocyte-targeted lipid nanoparticles (TLNPk). TLNPk were prepared by 
using a modified ethanol dilution method as described previously44. Briefly, 
DOTAP/DODMA/DOPC/DSPE-PEG2000-A5G33/Tween80 (20/30/27/3/20, mol/mol) were 
dissolved in ethanol, and mixed with siRNA in triethylammonium acetate buffer (20 mM, pH 4.5). 
The mixture was further diluted using PBS (10 mM phosphate, 135 mM NaCl, pH 7.4). The 
ethanol and free siRNA were removed by dialysis using a slide-a-lyzer dialysis cassette (Molecular 
weight cut-off, MWCO 20000). DSPE-PEG2000-A5G33 was replaced with DSPE-PEG2000 in the 
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non-targeted lipid nanoparticles (non-TLNP). If lipophilic fluorescence dye DiD were chosen to 
label the LNPs, 0.2% mol/mol amount of dye was added into the above formulation recipe. 
Encapsulation efficiency of TLNP. Encapsulation efficiency was performed by the Quant-iT 
RiboGreen RNA Kit (Invitrogen, Grand Island, NY, USA) as described previously.44 The 
unencapsulated siRNA content and the total siRNA content that was obtained upon lysis of the 
TLNP by 1% Triton were determined according to the manufacturer’s instruction using Multi-
Mode Microplate Readers (Biotek, Winooski, VT, USA) at 480 nm ex and 520 nm em. The 
encapsulation efficiency (EE) of siRNA was calculated with the following equation: 
EE =
Total siRNA ― unencapsulated siRNA
Total siRNA × 100%
The encapsulation efficiency of siRNA encapsulated keratinocyte targeted lipid nanoparticles 
(TLNPk/si) was also re-verified using gel retardation assay via 1% agarose gel. Electrophoresis was 
performed at 100 V for 20 min and visualized under a UV transilluminator (Bio-Rad laboratories, 
CA, USA).
Electron microscopy. The morphology of exosomes and TLNPk/si_hnRNPA2B1 was observed by 
transition electron microscopy (TEM, Japan). Briefly, the particles were ultracentrifuged at 
250,000 g at 4 ˚C, then the pellet was dispersed into deionized water and dropped on a copper grid, 
stained with NanoVan (vanadium-based negative stain from Nanoprobes.com, Yaphank, New 
York) and viewed on a Tecnai G2 12 Bio Twin electron microscope (FEI, Hillsboro, OR, USA) at 
the Electron Microscopy Center at the Indiana University School of Medicine.  
The morphology of exosome and other EVs was checked by scanning electron microscopy. Briefly, 
pellets containing either exosomes or eluent were resuspended in ddH2O with 0.1% formalin or 
other buffer and dropped onto clean silica wafers. After drying, samples were desiccated in a 
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vacuum chamber for at least 12 hours before analysis. Images were obtained after gold sputter 
coating using a field emission scanning electron microscope (JEOL 7800F, JEOL Japan) at a beam 
energy of 5 or 10 kV.
Nanoparticle tracking analysis. Mean particle diameter and concentration of extracellular 
vesicles and TLNκ were analyzed by Nanosight NS300 with a 532 nm laser and SCMOS camera 
(Malvern, Worcestershire, UK) as previously described.44 Briefly, samples were diluted 100: 1 or 
as needed in fresh milliQ to obtain 5-100 particles/frame. Samples were typically analyzed using 
5 runs of 30s collecting 25 frames per second (749 frames per run) with viscosity determined by 
the temperature and camera level highest available for sample (typically 15 or 14). The syringe 
pump speed was 60. NTA automatically compensates for flow in the sample so only Brownian 
motion is used for size determination. For processing results, the detection threshold was typically 
5 with automated blur size and max jump distance. Standard 100 nm latex spheres were run at 
1000:1 dilution in milliQ to check the instrument performance. Data were analyzed by NTA 3.0 
software (Malvern Instruments).
Zeta potential analysis. Surface charge ( potential) measurement of TLNPκ was determined by 
Zetasizer (Nano-Z, Malvern Instruments Ltd., UK). All samples were dispersed in double-distilled 
water and tested in volume-weighted size distribution mode. Aliquots of TLNPκ containing 
antimiR-107 were diluted in PBS with a series of pHs (50mM, from 2-11) to determine the pH 
dependency of surface charge. 
LDH release assay. Cytotoxicity of TLNPk was analyzed by measuring the lactate dehydrogenase 
(LDH) leakage in the media using the TOX-7 in vitro toxicology kit (Sigma, St. Louis, MO) as 
previously described.63 Briefly, HaCaT cells were seeded in 12-well plates (0.1 × 106 cells/well), 
and incubated overnight. The media were changed when the cells were treated with 
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TLNP/si_hnRNPA2B1. After incubation for the designated time (24 h and 48 h), cells culture media 
were collected and centrifuged, then the supernatant was transferred to a 96-well plate and 
incubated with the mixture of the assay substrate, enzyme and dye solutions for 20-30 min in dark 
at room temperature. The reaction was terminated by adding 1N HCl to each well. LDH 
absorbance was measured at 490 nm using the Bio-TEK ELX 808IU micro plate reader (Bio-TEK 
INSTRUMENTS, INC, Winooski, VT). 
MTT assay. Viability of keratinocytes post nanoparticle treatment was measured using a Vybrant 
MTT Cell Proliferation Assay Kit (Thermo Fisher Scientific) per the manufacturer’s instructions. 
At 24 h after treatment, cells were incubated in medium containing 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) for 4–6 h at 37°C with 5% CO2. After MTT treatment, 
medium was removed, and DMSO was added (10–20 min at 37°C with 5% CO2) to solubilize 
formazan produced as a result of MTT metabolism. DMSO extract from each well (100 μl) was 
collected in a 96-well plate, and formazan content was determined by reading absorbance at 540 
nm.64
Lipid nanoparticles and exosome uptake assay. For the cellular uptake of keratinocyte-targeted 
lipid nanoparticles studies, mixed culture of three different cells was performed. 1 105 cells ×
(HaCaT: HMEC: BJ1=1:1:3) were seeded in a 12-well plate in mixed media with 10% FBS and 
1% antibiotics and incubated overnight. DiD-loaded TLNP/si_hnRNPA2B1 and non-
TLNP/si_hnRNPA2B1 were prepared and added into the cells, then incubated at 37 °C. After 2 hours, 
cells were washed using PBS and fixed with 4% paraformaldehyde for 15 min at room temperature. 
HaCaT cells and HMEC were immunostained by K14 and CD31 respectively. Confocal images 
were acquired with a confocal laser-scanning system (CARL ZEISS confocal microscope LSM 
888). For live imaging of the uptake of TLNP by Kera 308, Kera cells were seeded in 4-well 
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tissue culture chambers at a density of 2 104 cells and incubated overnight. DiD-loaded ×
TLNP_FAM-siRNA and non-TLNP_FAM-siRNA were prepared and incubated with the cells. The 
cellular uptake was visualized for about 95 minutes.
For uptake of exosome studies by wound macrophages, Exo-GFP were isolated from murine skin. 
The concentration of the exosome was measured by Nanoparticle tracking analysis. The exosomes 
were stained with DiO and added to the day 3 ωmϕ and live cell imaging was performed. For 
blocking the C-type lectin receptors, a cocktail of neutralizing antibodies was used. Murine mincle 
(Mabg-mmel; Sigma), mouse dectin 1(MAB17561; R&D systems) and mouse SIGNR1 (AF18836; 
R&D systems) were used.
Ultrahigh Resolution Fourier Transform Mass Spectrometry. The accurate mass of the 
samples was determined using mass spectrometry. High-resolution mass spectrometry analyses 
were carried out in The Ohio State University, Campus Chemical Instrument Center’s Mass 
Spectrometry and Proteomics Facility (OSU CCIC MSP) by using a 15 T Bruker SolariXR FT-
ICR instrument (Bruker Daltonics, Billerica, MA).65 Matrix-assisted laser desorption/ionization 
(MALDI) was used with the alpha cyano hydroxycinnamic acid (HCCA) matrix in the positive 
ion mode. The matrix was purchased from Bruker Daltonics (Billarica, MA). The third harmonic 
of a Yag/Nd laser was used (351 nm) for MALDI with a 25% laser power. The samples were 
mixed with the saturated solution of the HCCA matrix with a matrix: analyte ratio of around 100:1. 
The resolution of the FT-ICR instrument was set to 150,000 at around m/z 2,500. The detection 
range was m/z 300-13,000 but no ions were observed beyond m/z 5,000. Standard FT-ICR ion 
optics parameters were used to maximize ion detection efficiency in the applied m/z range.  
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Transfection of XmiR-21 mimics. DharmaFECTTM 1 transfection reagent was employed to 
transfect HaCaT cells with XmiR-21 (100nM) (Dharmacon) as described previously.49 Cells and 
media were collected 48 h after transfection for further analysis as indicated.
Animals. Male C57BL/6 mice (aged 8-10 weeks) were obtained from Jackson Laboratory. All 
animal studies were performed in accordance with protocols approved by the Laboratory Animal 
Resource Center of Indiana University. No statistical methods were used to predetermine the 
sample size. Power analysis was not necessary for this study. The animals were tagged and grouped 
randomly using a computer-based algorithm (www.random.org). 
Wound models and in vivo TLNPk/siRNA delivery. For wounding, two 6-mm diameter full-
thickness excisional wounds were developed on the dorsal skin of mice with a 6-mm disposable 
biopsy punch and splinted with a silicon sheet to prevent contraction thereby allowing wounds to 
heal through granulation and re-epithelialization.66-68 TLNP /si-control and TLNP /si-hnRNPA2B1 were 
administrated into the wound edge by subcutaneous injection. For isolation of exosomes from 
wound-edge, four 8 mm diameter full-thickness excisional wounds were developed on the dorsal 
skin of mice with an 8-mm disposable biopsy punch without any stent.  During the wounding 
procedure, mice were anesthetized by low-dose isoflurane (1.5%-2%) inhalation as per standard 
recommendation. Tissue from the wounds (skin) was snap-frozen and stored at -80C until 
harvested for exosome collection described above. Each wound was digitally photographed at the 
time point indicated. Wound size was calculated by the ImageJ software.22 
The animals were euthanized at the indicated time and wound edges were collected for analyses. 
For wound-edge harvest, 1–1.5 mm of the tissue from the leading edge of the wounded skin was 
excised around the entire wound. The tissues were snap-frozen and if used for exosome harvest, 
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left in -80C until harvested for exosome collection described above. If used for IHC, tissues were 
collected either in 4% paraformaldehyde or in optimal cutting temperature (OCT) compound.
Tissue nanotransfection 2.0. In vivo TNT was performed as described previously with a 
modification in the chip design.31 The hollow microneedle array was fabricated on a double side 
polished Silicon wafer using a standard semiconductor process in a cleanroom environment. First, 
the Si wafer was wet oxidized in a furnace at 1150 ºC to grow 4 µm thermal oxide on both sides 
that served as a hard mask during the deep silicon etching. A 10 µm thick, positive photoresist of 
AZ 9260 was spin-coated on one side of the silicon wafer followed by a prebake at 110 ºC for 10 
min. A direct laser writing system was used to expose a layout of 25 µm circle arrays followed by 
development in a diluted AZ400K solution to remove the exposed area. The 4 µm oxide was 
removed by a plasma etcher using CHF3 chemistry. The wafer was then transferred to another 
plasma etching system to perform a deep Si etching called Bosch process, a common 
semiconductor process to achieve a vertical etching profile with a high-aspect ratio. After silicon 
etching of about 350 - 450 µm in depth to form the reservoir arrays, the wafer was flipped for the 
next step to etch the hollow microneedle arrays. A donut-shaped pattern was exposed onto the 
resist and the pattern was transferred to the oxide using the same set of steps mentioned above. 
Then, the wafer was etched by the Bosch process until the hollow microneedles are connected to 
the reservoirs so that the cargo or the plasmid DNA fluid can freely flow from the reservoir to the 
hollow microchannel. The SEM images showed the fabricated silicon hollow microneedle array 
(Fig. 1C) that has a length of 170 µm, an outer diameter of 50 µm and a hollow diameter of 4 µm. 
When an electric pulse was applied between the TNT chip and the tissue, the negatively charged 
plasma DNA will travel from the reservoir to nearby target cells by electrophoresis and enter them 
by electroporation. To test the TNT2.0 delivery efficiency, FAM-DNA (5′/56-
FAM/TACCGCTGCGACCCTCT-3′) was used in murine skin. 
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Trans-epidermal water loss. TEWL serves as a reliable index to evaluate the skin barrier function 
in vivo 23-25. TEWL was measured from the skin and wounds using DermaLab TEWL Probe 
(cyberDERM, Broomall, PA). The data were expressed in g.m−2.h−1.
RNA extraction and quantitative real-time PCR. RNA from cells or exosome was extracted 
using miRVana miRNA isolation kit (Ambion) according to the manufacture’s protocol.21, 69 For 
determination of miR expression, specific TaqMan assays for miRs and the TaqMan miRNA 
reverse transcription kit were used, followed by real time PCR using the Universal PCR Master 
Mix (Applied Biosystems, Foster City, CA). mRNA was quantified by real-time or quantitative 
(Q) PCR assay using the double-stranded DNA binding dye SYBR Green-I.21, 69 
High-resolution automated electrophoresis of RNA. The RNA isolated from Exo-GFP was 
analyzed in Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, California).70  
Western blots. Western blot was performed using antibodies against human hnRNPA2B1 
(Sigma-Aldrich; SAB1403931, 1:500), mouse hnRNPA2B1 (Sigma-Aldrich; HPA001666, 
1:200), TSG101 (Abcam; ab125011, 1:1000), Alix (Novus Biologicals; JM 85-31, 1:1000), 
HSP90 (Abcam; ab59459, 1:1000), Flotillin 1 (Abcam; ab133497, 1:200), GM130 (Abcam; 
ab52649, 1:1000), Prohibitin (Abcam; ab28172, 1:200). Signal was visualized using 
corresponding HRP-conjugated secondary antibody (Amersham, 1:3,000) and ECL Plus™ 
Western Blotting Detection Reagents (Amersham). -actin (Sigma-Aldrich; A5441, 1: 2000) 
served as loading control.21, 22 
Immunohistochemistry (IHC) and microscopy. Immunohistochemistry was performed as 
described previously.71 Immunostainings of  F4/80 (Bio-Rad , MCA497R; 1:200), K14 (Covance, 
PRB-155P-100; 1:400), GFP (Abcam, ab13970; 1:500), MPO (Abcam, ab9535; 1:50), Arginase 
(Abcam; 203490, 1:100), iNOS (Abcam; ab115819, 1:100), hnRNPA2B1(Sigma-Aldrich; 
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HPA001666, 1:50),  Occludin (Invitrogen, 711500; 1:200), ZO-1 (Invitrogen, 617300; 1:200), 
ZO-2 (Invitrogen, 389100; 1:200), Loricrin (Biolegend, PRB-145P; 1:400) , Filaggrin (Covance, 
PRB-417P; 1:500) CD31 (BD Pharmingen, 550274; 1:400), Col1A2 (Santa Cruz, sc-393573; 
1:200), CDH5 (Abcam; ab91064, 1:200),  were performed on paraffin and cryosections of skin 
sample using specific antibodies as indicated.57  The specificity of the antibodies was validated 
using rabbit isotype control (Abcam, ab27478; 1:400). Briefly, the sections blocked with 10% 
normal goat serum, and incubated with specific antibodies overnight at 4°C. Signal was visualized 
by subsequent incubation with fluorescence-tagged appropriate secondary antibodies (Alexa 488-
tagged α-rabbit, 1:200; Alexa 568-tagged α-rabbit, 1:200; Alexa 568-tagged α-rat, 1:200, Alexa 
488-tagged α-chicken, 1:200) and counter stained with DAPI. Images were captured by
microscope using super-resolution airyscan laser-scanning confocal system (CARL ZEISS 
confocal microscope LSM 888) and (Axio Scan.Z1, Zeiss, Germany). Quantification of 
fluorescent intensity of image was analyzed using Zen software (Zen blue 3.1) and ImageJ 
software with colocolization plugin.72, 73 
Statistical analysis. GraphPad Prism (GraphPad Software) v8.0 was used for statistical analyses. 
No statistical methods were used to predetermine the sample size. The ΔΔCt value was used for 
statistical analysis of all RT-qPCR data. Statistical analysis between multiple groups were 
performed using one-way analysis of variance with the post-hoc Sidak or Bonferroni multiple 
comparison test. Statistical analysis between two groups were performed using unpaired Student’s 
two-sided t tests. P < 0.05 was considered statistically significant. Significance levels and exact P 
values were indicated in all relevant figures. Data were assumed to be normally distributed for all 
analyses conducted. Data for independent experiments were presented as means ± SEM unless 
otherwise stated.
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The Supporting Information is available free of charge 
Isolation and characterization of exosomes from human keratinocyte conditioned culture media 
(S1); identification and isolation of keratinocyte-derived exosome in murine skin (S2); conversion 
of wound macrophage phenotype following uptake of keratinocyte derived exosome (S3); 
specificity, uptake, and cytotoxicity of human keratinocyte-targeted lipid nanoparticles (TLNP) 
(S4); abundance of miR-21-5p in keratinocytes and exosome after transfection of XmiR-21-5p 
(S5); delivery of TLNP encapsulating si-hnRNPA2B1 did not change hnRNPA2B1 expression in 
other cell types and did not compromise Exo-GFP abundance or wound closure (S6), did not 
compromise recruitment of inflammatory cells post-wounding (S7), and results in persistence of 
inflammatory cells post-wound closure (S8). N-glycan analysis of exosome isolated from skin and 
wound-edge tissue (Table S1). Live-cell confocal images showing uptake of non-TLNP and 
TLNP by mouse keratinocytes using LSM 880 (mp4 movies S1-S2). Live-cell confocal images 
showing uptake of Exo-GFP by mouse wound macrophages with or without inhibition of C-type 
lectin using LSM 880 (mp4 movies S3-S4).
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Figure 1. Isolation and characterization of keratinocyte-derived exosomes from murine skin. 
(A) Quantification of extracellular vesicles and exosomes from murine skin and day 5 wound-edge 
tissue of C57BL/6 mice. (n=11, 12) (B) Schematic diagram of keratin 14 (K14) promoter-driven 
recombinant plasmids encoding CD9, CD63 or CD81 with “in frame” GFP reporter. (C) 
Representative scanning electron microscopic images of tissue nanotransfection (TNT) chip 2.0. 
(D) Schematic diagram showing the delivery of the three K14 promoter-driven plasmids via TNT 
in the dorsal murine skin. (E) Confocal microscopic images showing presence of keratinocyte 
derived exosome (Exo-GFP) in dermis (left) and super-resolution confocal microscopic images 
showing GFP labelled exosome (right). The white dash line shows epidermal-dermal junction. 
Scale, 10µm and 2µm.  (F) Schematic diagram showing exosome isolation process from murine 
skin tissue post-TNT with the three plasmids. MP: membrane particles; AB: apoptotic bodies. (G) 
Particle size distribution of keratinocyte-derived exosomes (Exo−GFP), non-keratinocyte-derived 
exosomes (Exonon-GFP), and flow through (membrane particles and apoptotic bodies) from murine 
skin. (n=10) (H) Representative Scanning Electron Microscopy (SEM) images of murine 
keratinocyte-derived exosomes. Scale, 100 nm. (I-J) Binding of TSG-101 PE with the murine 
keratinocyte-derived exosome was further tested by autocorrelation curves as determined by 
fluorescence correlation spectroscopy (FCS) (I) and time-resolved fluorescence anisotropy (J). 
(n=10) (K) Flow cytometric analysis of murine skin keratinocyte-derived exosome on GFP-trap 
magnetic beads showing binding of TSG-101 PE, Alix-FITC, Flotillin 1-PE and HSP90-FITC 
antibodies.  The histograms demonstrate the shift in fluorescence after binding of murine Exo-GFP 
on the GFP-trap magnetic beads with the respective antibody.  All data were shown as 
mean ± SEM. Data in A were analyzed by two-tailed unpaired Student’s t-test. Data in J were 
analyzed by one-way ANOVA with the post-hoc Bonferroni’s multiple comparison test.  
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Figure 2: Comparative analysis of keratinocyte-derived exosome with exosome isolated from 
cell culture conditioned media. (A) Schematic diagram showing exosome isolation process from 
murine keratinocyte (Kera308) cultured media with and without transfection with keratin 14 
promoter-driven recombinant plasmids encoding CD9, CD63 or CD81 with “in frame” GFP 
reporter. (B) The particle size distribution of exosomes and eluent (membrane particles and 
apoptotic bodies) from murine keratinocyte cultured media. (n=6) (C) Representative 
Transmission Electron Microscopy (TEM) images of exosomes isolated using GFP beads and CD-
beads. Scale, 200 nm (D) Flow cytometric analysis of murine keratinocyte-derived exosome on 
CD magnetic beads (CD63, CD9 and CD81) and GFP-beads showing binding of TSG-101 PE 
antibody. (E-F) Binding of TSG-101 PE with the murine keratinocyte-derived exosome was 
further tested by autocorrelation curves as determined by fluorescence correlation spectroscopy 
(FCS) (E) and time-resolved fluorescence anisotropy (F) (n=20). All data were shown as 
mean ± SEM. Data in F were analyzed by one-way ANOVA with the post-hoc Bonferroni’s 
multiple comparison test.  
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Figure 3. Characterization of keratinocyte-derived exosome from murine skin and
wound-edge tissue. (A) Murine dorsal skin was transfected with keratin 14 promoter-driven
recombinant plasmids encoding CD9, CD63 or CD81 with “in frame” GFP reporter via TNT.
The keratinocyte-derived exosomes were isolated from skin and day 5 wound-edge tissue
using GFP magnetic trap and quantified using NTA. Data shown as mean ± SEM and were
analyzed by two-tailed unpaired Student’s t-test. (n=8) (B) High-resolution automated
electrophoresis of RNA isolated from skin and wound-edge Exok-GFP. RNA in wound-edge
Exok-GFP was significantly abundant compared to that of skin Exok-GFP.
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Figure 4. Comparative glycomics of the Exo−GFP isolated from skin and wound-edge tissue. 
Representative m/z ratios, relative intensities, and proposed structures of N-glycans released from 
skin and wound-edge tissue derived Exo-GFP, methylamidated, labeled with Girard’s reagent T, 
and analyzed by CE-MS. Data analysis determined that 19 and 7 structures were found exclusive 
to skin and day 5 wound-edge tissue, respectively. 
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Figure 5: Design and synthesis of keratinocyte-targeted lipid nanoparticles (TLNPk) to
inhibit miRNA packaging within exosome. (A) Schematic representation of the
keratinocyte-targeted lipid nanoparticles TLNPk. (B) Mass spectrometric analysis of DSPE-
PEG2000-A5G33 and DSPE-PEG-NHS using MALDI-TOF. (C) Zeta potentials of TLNPk at
different pH. (D) Gel retardation assay of TLNPk showing encapsulation efficiency of
TLNPk. (E) Representative Transmission Electron Microscopy (TEM) image of TLNPk.
Scale, 500 nm. (F) Representative nanoparticle tracking analysis (NanoSight) showing
particle size distribution and concentration of non-TLNPk and TLNPk.
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Figure 6: Specificity, uptake and cytotoxicity of keratinocyte-targeted lipid nanoparticles 
(TLNP). (A) Schematic diagram showing experimental design to test the specificity of TLNP in 
mixed culture. (B) Confocal microscopic images showing selective uptake of TLNP by human 
keratinocytes at 4h compared with non-TLN in mixed culture cells (HaCaT: HMEC: BJ-1=1:1:3). 
K, keratinocyte; F, fibroblasts; E, endothelial cells. Scale; 20 µm. (C) In vitro LDH assay of 
TLNPk. (n=10) (D) Live-cell confocal images showing rapid uptake of TLNP by mouse 
keratinocytes compared to non-TLNPk. Scale, 10 µm. Indicate movies in the supplement.  
Data in C were shown as mean ± SEM and were analyzed by one-way ANOVA with the post-hoc 
Sidak’s multiple comparison test. 
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Figure 7: TLNPk/si-hnRNPA2B1 inhibits packaging of miRNA within the exosome in keratinocyte.  
(A) Schematic diagram showing experimental design to test the efficacy of TLNP/si-hnRNPA2B1 in 
inhibiting miRNA packaging within the exosome in keratinocyte. (B) Western blot analysis of 
hnRNPA2B1 in human keratinocytes 72 h after treatment with TLNP encapsulating either si-
control or si-hnRNPA2B1. Quantification of hnRNPA2B1 expression from immunoblots. (n=8,7) 
(C) The exosomes isolated from keratinocyte conditioned media 48h after transfection and 
Nanoparticle Tracking Analysis was done. The exosome concentration in the conditioned media 
48 h after treatment with TLNP encapsulating either si-control or si-hnRNPA2B1were plotted 
graphically. (n=12) (D) High-resolution automated electrophoresis of RNA isolated from 
exosomes in the conditioned media 48 h after treatment with TLNP encapsulating either si-control 
or si-hnRNPA2B1were plotted graphically. (E) The RNA concentration per 10
9 exosomes in the 
conditioned media 48 h after treatment with TLNP encapsulating either si-control or si-
hnRNPA2B1were plotted graphically. (n=12) (F) The abundance of miR-21-5p in exosome 
isolated from the conditioned media 48 h after treatment with TLNP encapsulating either si-
control or si-hnRNPA2B1were plotted graphically. (n=12). Data in B, C, E and F were shown as 
mean ± SEM and were analyzed by two-tailed unpaired Student’s t-test. 
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Figure 8: Delivery of keratinocyte-targeted lipid nanoparticles encapsulating si-hnRNPA2B1 
compromised the quality of wound closure. (A) Western blot analysis of hnRNPA2B1 in murine 
keratinocytes 48 h after treatment with TLNPk encapsulating either si-control or si-hnRNPA2B1. 
β-actin was used as loading control. Quantification of hnRNPA2B1 expression from immunoblots. 
(n=6) (B) Schematic diagram showing excisional wounding (6mm stented wound), application of 
TLNPk encapsulating either si-control or si-hnRNPA2B1 and tissue harvesting time points in 
C57BL/6 (wild type) mice. (C) Confocal microscopic image showing localization of DID-labeled 
TLNPk (red) in the epidermis (green) at 24h after post-treatment with DID-labeled TLNPk by 
subcutaneous injection. Scale, 50 µm. (D) Representative coimmunofluorescence images showing 
hnRNPA2B1 (green) and DAPI counterstaining in C57BL/6 mice at day 6 post wounding. White 
dashed lines indicate the dermal-epidermal junction. Scale, 50µm. (E) Quantification of excisional 
stented punch wounds (6mm) at different days by digital planimetry following delivery of TLNPk 
encapsulating either si-control or si-hnRNPA2B1. (n=6,8) (F) Representative Hematoxylin and 
Eosin (H&E) staining of day 10 murine wound tissue treated with TLNPk encapsulating either si-
control or si-hnRNPA2B1. Scale, 200µm (for mosaic images) and 20µm (for inset images). (G) 
Representative coimmunofluorescence staining of F4-80 (red) with DAPI counterstaining in 
wound-edge tissue at day 10 post-wounding in C57BL/6 mice treated with either scramble or si-
hnRNPA2B1 encapsulated keratinocyte targeted lipid nanoparticles. Scale, 50μm. Quantification
of F4-80 intensity in wound-edge tissue at day 10 post-wounding. Each dot corresponds to one 
quantified ROI, except the blue and red dots, which correspond to the mean of each mouse. At 
least 5 ROI per mouse. (n = 4) (H) Representative coimmunofluorescence staining of F4-80 (red) 
and Arginase (green; proresolution macrophage marker) with DAPI counterstaining in day 10 
wound-edge tissue of C57BL/6 mice treated with TLNPk encapsulating either si-control or si-
hnRNPA2B1. The colocalization of red and green are shown as white dots.  Scale, 20μm. (I) 
Representative coimmunofluorescence staining of F4-80 (red) and iNOS (green; proinflammatory 
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macrophage marker) with DAPI counterstaining in day 10 wound-edge tissue of C57BL/6 mice 
treated with TLNP encapsulating either si-control or si-hnRNPA2B1. The colocalization of red 
and green are shown as white dots.  Scale, 20μm. Data in A, G and E were shown as mean ± SEM 
and were analyzed by two-tailed unpaired Student’s t-test. 
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Figure 9: Delivery of keratinocyte-targeted lipid nanoparticles encapsulating si-
hnRNPA2B1 compromised the quality of wound closure. (A) Transepidermal water loss 
(TEWL) after C57BL/6 mice treated with TLNPκ encapsulating either si-control or si-
hnRNPA2B1. (n=10) (B) Representative coimmunofluorescence staining of loricrin with DAPI 
counterstaining in wound-edge tissue at day 10 post-wounding in C57BL/6 mice treated with 
either scramble or si-hnRNPA2B1 encapsulated keratinocyte targeted lipid nanoparticles. Scale, 
200μm. Quantification of loricrin intensity in wound-edge tissue at day 10 post-wounding. Each
dot corresponds to one quantified ROI, except the blue and red dots, which correspond to the 
mean of each mouse. At least 5 ROI per mouse. (n = 4) (C) TLNPκ/si-hnRNPA2B1 treatment 
compromised the expression of ZO-1 (green), ZO-2 (red), filaggrin (green) and occludin (red) in 
murine skin at day 10. Sections were counterstained with DAPI (blue). Dermal-epidermal 
junction is indicated by a dashed white line. Scale bars, 50 μm. The abundance of junctional 
proteins was quantified. Each dot corresponds to one quantified ROI, except the blue and red 
dots, which correspond to the mean of each mouse. At least 5 ROI per mouse. (n = 3, 4). Data 
expressed as mean ± SEM and were analyzed by two-tailed unpaired Student’s t-test. 
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